- Home
- WFF vs RVPH Comparison
WFF vs RVPH Comparison
Compare WFF & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- RVPH
- Stock Information
- Founded
- WFF 1984
- RVPH 2006
- Country
- WFF Malaysia
- RVPH United States
- Employees
- WFF N/A
- RVPH N/A
- Industry
- WFF Miscellaneous manufacturing industries
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- RVPH Health Care
- Exchange
- WFF Nasdaq
- RVPH Nasdaq
- Market Cap
- WFF 18.3M
- RVPH 18.1M
- IPO Year
- WFF 2025
- RVPH N/A
- Fundamental
- Price
- WFF $0.62
- RVPH $0.50
- Analyst Decision
- WFF
- RVPH Strong Buy
- Analyst Count
- WFF 0
- RVPH 6
- Target Price
- WFF N/A
- RVPH $3.33
- AVG Volume (30 Days)
- WFF 60.5K
- RVPH 7.8M
- Earning Date
- WFF 04-30-2026
- RVPH 11-13-2025
- Dividend Yield
- WFF N/A
- RVPH N/A
- EPS Growth
- WFF N/A
- RVPH N/A
- EPS
- WFF 0.00
- RVPH N/A
- Revenue
- WFF $4,572,290.00
- RVPH N/A
- Revenue This Year
- WFF N/A
- RVPH N/A
- Revenue Next Year
- WFF N/A
- RVPH N/A
- P/E Ratio
- WFF $115.59
- RVPH N/A
- Revenue Growth
- WFF N/A
- RVPH N/A
- 52 Week Low
- WFF $0.45
- RVPH $0.25
- 52 Week High
- WFF $29.26
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- RVPH 45.49
- Support Level
- WFF N/A
- RVPH $0.45
- Resistance Level
- WFF N/A
- RVPH $0.59
- Average True Range (ATR)
- WFF 0.00
- RVPH 0.05
- MACD
- WFF 0.00
- RVPH -0.01
- Stochastic Oscillator
- WFF 0.00
- RVPH 24.68
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.